187 related articles for article (PubMed ID: 35480865)
1. In Silico Establishment and Validation of Novel Lipid Metabolism-Related Gene Signature in Bladder Cancer.
Sun X; Zhang Y; Chen Y; Xin S; Jin L; Liu X; Zhou Z; Zhang J; Mei W; Zhang B; Yao X; Yang G; Ye L
Oxid Med Cell Longev; 2022; 2022():3170950. PubMed ID: 35480865
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer.
Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
Lipids Health Dis; 2021 Oct; 20(1):146. PubMed ID: 34706720
[TBL] [Abstract][Full Text] [Related]
3. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
Wang Z; Tu L; Chen M; Tong S
BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
[TBL] [Abstract][Full Text] [Related]
4. In silico development and clinical validation of novel 8 gene signature based on lipid metabolism related genes in colon adenocarcinoma.
Jiang C; Liu Y; Wen S; Xu C; Gu L
Pharmacol Res; 2021 Jul; 169():105644. PubMed ID: 33940186
[TBL] [Abstract][Full Text] [Related]
5. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
6. In silico development and experimental validation of a novel 7-gene signature based on PI3K pathway-related genes in bladder cancer.
Wang L; Wang Y; Bi J
Funct Integr Genomics; 2022 Oct; 22(5):797-811. PubMed ID: 35896848
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Notch Pathway-Related Genes for Predicting Prognosis and Tumor Microenvironment Status in Bladder Cancer.
Sun X; Xin S; Li W; Zhang Y; Ye L
Front Genet; 2022; 13():928778. PubMed ID: 35846128
[No Abstract] [Full Text] [Related]
8. Glycometabolism and lipid metabolism related genes predict the prognosis of endometrial carcinoma and their effects on tumor cells.
Lin X; Zheng J; Cai X; Liu L; Jiang S; Liu Q; Sun Y
BMC Cancer; 2024 May; 24(1):571. PubMed ID: 38720279
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis.
Zhu M; Zeng Q; Fan T; Lei Y; Wang F; Zheng S; Wang X; Zeng H; Tan F; Sun N; Xue Q; He J
Front Immunol; 2022; 13():783495. PubMed ID: 35222371
[TBL] [Abstract][Full Text] [Related]
10. Establishment and Validation of a Tumor Microenvironment Prognostic Model for Predicting Bladder Cancer Survival Status Based on Integrated Bioinformatics Analyses.
Chen Q; Yin G; He X; Jiang T; Zhou H; Wu Y; Li Y
Evid Based Complement Alternat Med; 2022; 2022():4351005. PubMed ID: 36225190
[TBL] [Abstract][Full Text] [Related]
11. A prognostic index based on a fourteen long non-coding RNA signature to predict the recurrence-free survival for muscle-invasive bladder cancer patients.
Zhang X; Zhang M; Zhang X; Zhu X; Wang J
BMC Med Inform Decis Mak; 2020 Jul; 20(Suppl 3):136. PubMed ID: 32646427
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a four-lipid metabolism gene signature for diagnosis of pancreatic cancer.
Ye Y; Chen Z; Shen Y; Qin Y; Wang H
FEBS Open Bio; 2021 Nov; 11(11):3153-3170. PubMed ID: 33386701
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel metabolism-related gene signature associated with the survival of bladder cancer.
Li X; Fu S; Huang Y; Luan T; Wang H; Wang J
BMC Cancer; 2021 Nov; 21(1):1267. PubMed ID: 34819038
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Lipid Metabolism-Related Genes for Predicting Tumor Immune Microenvironment Status and Prognosis in Prostate Cancer.
Zhang Y; Kong X; Xin S; Bi L; Sun X
J Oncol; 2022; 2022():8227806. PubMed ID: 36106334
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
Song Y; Qu H
BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
[TBL] [Abstract][Full Text] [Related]
16. Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer.
Song Y; Jin D; Chen J; Luo Z; Chen G; Yang Y; Liu X
Aging (Albany NY); 2020 Jun; 12(12):12051-12073. PubMed ID: 32579540
[TBL] [Abstract][Full Text] [Related]
17. An
Han Y; Wong FC; Wang D; Kahlert C
Cancer Inform; 2022; 21():11769351221100727. PubMed ID: 35645555
[TBL] [Abstract][Full Text] [Related]
18. Identification of a 5-Gene-Based Scoring System by WGCNA and LASSO to Predict Prognosis for Rectal Cancer Patients.
Huang H; Xu S; Chen A; Li F; Wu J; Tu X; Hu K
Anal Cell Pathol (Amst); 2021; 2021():6697407. PubMed ID: 33833937
[TBL] [Abstract][Full Text] [Related]
19. An Individualized Prognostic Signature for Clinically Predicting the Survival of Patients With Bladder Cancer.
Liu Q; Wang Y; Gao H; Sun F; Wang X; Zhang H; Wang J
Front Genet; 2022; 13():837301. PubMed ID: 35422849
[No Abstract] [Full Text] [Related]
20. Construction and Validation of a Prognostic Model of Metabolism-Related Genes Driven by Somatic Mutation in Bladder Cancer.
Wei L; Ji L; Han S; Xu M; Yang X
Front Biosci (Landmark Ed); 2023 Oct; 28(10):242. PubMed ID: 37919060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
